Saccharomyces as a vaccine against systemic candidiasis

Immunological Investigations

Volumn 41, Issue 8, 2012, Pages 847-855

  Liu, Min ^a,b,c   Clemons, Karl V ^a,b,c   Johansen, Maria E ^a   Martinez, Marife ^a   Chen, Vicky ^a   Stevens, David A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antifungal vaccine; Candidiasis; Saccharomyces

Indexed keywords

ALUMINUM POTASSIUM SULFATE; FUNGUS VACCINE; INACTIVATED VACCINE; SACCHAROMYCES CEREVISIAE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; IMMUNIZATION; INVASIVE CANDIDIASIS; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SURVIVAL RATE;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA ALBICANS; CANDIDIASIS; CROSS REACTIONS; DISEASE MODELS, ANIMAL; EPITOPES, B-LYMPHOCYTE; FUNGAL VACCINES; HUMANS; IMMUNITY, ACTIVE; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED STRAINS; SACCHAROMYCES; VACCINES, INACTIVATED;

EID: 84870920773     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.692418     Document Type: Article

References (36)

1. Bozza, S., Montagnoli, C., Gaziano, R., Rossi, G., Nkwanyuo, G., Bellocchio, S., Romani, L. (2004). Dendritic cell-based vaccination against opportunistic fungi. Vaccine 22: 857-864.
2. Capilla, J., Clemons, K. V., Liu, M., Levine, H. B., Stevens, D. A. (2009). Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. Vaccine 27:3662-3668.
3. Cardenas-Freytag, L., Cheng, E., Mayeux, P., Domer, J. E., Clements, J. D. (1999). Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel muco-sal adjuvant, LT(R192G), against systemic candidiasis. Infect. Immun, 67: 826-833.
4. Cassone, A. (2008). Fungal vaccines: real progress from real challenges. Lancet Infect. Dis. 8:114-124.
5. Clemons, K. V., Stevens, D. A. (2001). Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis. J. Antimicrob. Chemother. 47:183-186.
6. Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., Filler, S. G., Masso-Welch, P., Edgerton, M., Gaffen, S. L. (2009). Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206:299-311.
7. Cutler, J. E., Deepe, G. S., Jr., Klein, B. S. (2007). Advances in combating fungal diseases: vaccines on the threshold. Nat. Rev. Microbiol. 5:13-28.
8. Diaz-Arevalo, D., Hong, T. B., Ito, J. I., Clemons, K. V., Stevens, D. A., Kalkum, M. (2011). Quantitative and comparative proteomic analyses of pathogenic fungi. 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, American Society for Microbiology: Abstr. M-310.
9. DiMiceli, L., Pool, V., Kelso, J. M., Shadomy, S. V., Iskander, J. (2006). Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 24:703-707.
10. Ferwerda, G., Netea, M. G., Joosten, L.A., van der Meer, J. W., Romani, L., Kullberg, B. J. (2010). The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans. Vaccine 28:614-622.
11. Fidel, P. L., Jr., Ginsburg, K. A., Cutright, J. L., Wolf, N. A., Leaman, D., Dunlap, K., Sobel, J. D. (1997). Vaginal-associated immunity in women with recurrent vulvova-ginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J. Infect. Dis. 176:728-739.
12. Franzusoff, A., Duke, R. C., King, T. H., Lu, Y., Rodell, T. C. (2005). Yeasts encoding tumour antigens in cancer immunotherapy. Expert Opin Biol Ther 5:565-575.
13. Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., Benjamin, L. E., Sanza, L. T., Huie, S., Yeo, S. F., Brandt, M. E., Warnock, D. W. (2004). Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42:1519-1527.
14. Han, Y., Ulrich, M. A., Cutler, J. E. (1999). Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis. 179:1477-1484.
15. Hanson, L. H., Perlman, A. M., Clemons, K. V., Stevens, D. A. (1991). Synergy between cilofungin and amphotericin B in a murine model of candidiasis. Antimicrob. Agents Chemother. 35:1334-1337.
16. Hoeprich, P. D., Finn, P. D. (1972). Obfuscation of the activity of antifungal antimicrobics by culture media. J. Infect. Dis. 126:353-361.
17. Huang, W., Na, L., Fidel, P. L., Schwarzenberger, P. (2004). Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190: 624-631.
18. La Sala, A., Urbani, F., Torosantucci, A., Cassone, A., Ausiello, C. M. (1996). Mannoproteins from Candida albicans elicit a Th-type-1 cytokine profile in human Candida specific long-term T cell cultures. J. Biol. Regul. Homeost. Agents 10:8-12.
19. Lachin, J. M. (1999). Worst-rank score analysis with informatively missing observations in clinical trials. Control Clin. Trials 20:408-422.
20. Lin, L., Ibrahim, A. S., Xu, X., Farber, J. M., Avanesian, V., Baquir, B., Fu, Y., French, S. W., Edwards, J. E., Jr., Spellberg, B. (2009). Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 5:e1000703.
21. Liu, M., Capilla, J., Johansen, M. E, Alvarado, D., Martinez, M., Chen, V. Clemons, K. V., Stevens, D. A. (2011a). Saccharomyces as a vaccine against systemic aspergillosis. J. Med. Microbiol. 60:1423-1432.
22. Liu, M., Clemons, K. V., Bigos, M., Medovarska, I., Brummer, E., Stevens, D. A. (2011b). Immune responses induced by heat killed Saccharomyces cerevisiae: A vaccine against fungal infection. Vaccine 29:1745-1753.
23. Liu, M., Clemons, K., Bystricky, S., Stevens, D. (2010). Glycans and conjugates as vaccines against coccidioidomycosis. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, Am. Soc. Microbiol.: Abstr G1-1657
24. Liu, M., Machova, E., Nescakova, Z., Medovarska, I., Clemons, K.V., Martinez, M., Chen, V., Bystricky, S., Stevens, D.A. Vaccination with mannan protects mice against systemic aspergillosis. Med. Mycol., in press.
25. Lu, Y., Bellgrau, D., Dwyer-Nield, L. D., Malkinson, A. M., Duke, R. C., Rodell, T. C., Franzusoff, A. (2004). Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy. Cancer Res. 64:5084-5088.
26. Majumder, T., Liu, M., Chen, V., Martinez, M., Alvarado, D., Clemons, K. V., Stevens, D. A. (2011). Killed Saccharomyces cerevisiae protects against lethal challenge with Cryptococcus grubii. 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, American Society for Microbiology: Abstr. G1-769.
27. Morrison, C. J., Stevens, D. A. (1990). Comparative effects of cilofungin and ampho-tericin B on experimental murine candidiasis. Antimicrob. Agents Chemother. 34: 746-750.
28. Munson, S., Parker, J., King, T., Lu, Y., Kelley, V., Guo, Z., Borges, V., Franzusoff, A. (2008). Coupling innate and adaptive immunity with yeast-based cancer immu-notherapy. In: Orentas, R., Hodge, J. W., and Johnson, B. D., editors. Cancer Vaccines and Tumor Immunity. John Wiley & Sons: Hoboken, NJ, pp. 131-149.
29. Raska, M., Belakova, J., Horynova, M., Krupka, M., Novotny, J., Sebestova, M., Weigl, E. (2008). Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis. Med. Mycol. 46:411-420.
30. Shih, W. (2002). Problems in dealing with missing data and informative censoring in clinical trials. Curr. Control Trials Cardiovasc. Med. 3:4.
31. Spellberg, B. J., Ibrahim, A. S., Avanesian, V., Fu, Y., Myers, C., Phan, Q. T., Filler, S. G., Yeaman, M. R., Edwards, J. E., Jr. (2006). Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis. J. Infect. Dis. 194:256-260.
32. Stevens, D. A., Clemons, K. V., Liu, M. (2010). Developing a vaccine against aspergillosis. Med. Mycol. 49(Suppl 1): S170-S176.
33. Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., Rappuoli, R., Cassone, A. (2005). A novel glyco-conjugate vaccine against fungal pathogens. J. Exp. Med. 202:597-606.
34. Warnock, D. W. (2007). Trends in the epidemiology of invasive fungal infections. Nippon Ishinkin Gakkai Zasshi 48:1-12.
35. Wu, X., Lipinski, T., Carrel, F. R., Bailey, J. J., Bundle, D. R. (2007). Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine. Org. Biomol. Chem. 5:3477-3485.
36. Xin, H., Dziadek, S., Bundle, D. R., Cutler, J. E. (2008). Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc. Natl. Acad. Sci. USA 105:13526-13531.